- Cat. No.
- A59580
RAP-103
RAP-103 is a potent orally active CCR antagonist that targets the CCR pathway to provide synaptic protection. It effectively inhibits and reverses cytoskeletal alterations induced by PrPC/NOX signaling. RAP-103 is particularly relevant for research applications focused on Alzheimer's disease, offering insights into neuroprotective mechanisms and potential therapeutic strategies.
Out of stock
All 3 sizes